Status:
COMPLETED
Study of Oglemilast for the Prevention of Asthma.
Lead Sponsor:
Forest Laboratories
Conditions:
Exercise-Induced Asthma
Eligibility:
All Genders
18-50 years
Phase:
PHASE2
Brief Summary
The purpose of this study is to determine whether it is effective in the treatment of exercise-induced asthma and investigate the safety of oglemilast.
Eligibility Criteria
Inclusion
- stable mild asthma patients who exhibit at least a 20% decrease in FEV1 following exercise.
Exclusion
- pulmonary disease other than asthma, psychiatric illness, active cardiac disease, high blood pressure, history of substance abuse, current smokers.
Key Trial Info
Start Date :
May 1 2006
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
October 1 2006
Estimated Enrollment :
24 Patients enrolled
Trial Details
Trial ID
NCT00322283
Start Date
May 1 2006
End Date
October 1 2006
Last Update
April 10 2012
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Forest Investigative Site
Los Angeles, California, United States, 90025
2
Forest Investigative Site
North Dartmouth, Massachusetts, United States, 02747